The pharmacokinetics of intratracheally instilled and intravenously injected gentamicin were compared in the rat and analyzed by a one-compartment open model. The maximum concentration of gentamicin in plasma occurred within 10 min after intratracheal instillation. Considerable amounts of gentamicin were absorbed from lungs after intratracheal insilation, as shown by its concentrations in plasma and elimination in urine. The data suggest that the absorption of gentamicin from the pulmonary system would be sufficient to maintain therapeutic levels of this agent in plasma.
The pharmacokinetics of intratracheally instilled and intravenously injected gentamicin were compared in the rat and analyzed by a one-compartment open model. The maximum concentration of gentamicin in plasma occurred within 10 min after intratracheal instillation. Considerable amounts of gentamicin were absorbed from lungs after intratracheal insilation, as shown by its concentrations in plasma and elimination in urine. The data suggest that the absorption of gentamicin from the pulmonary system would be sufficient to maintain therapeutic levels of this agent in plasma.
The amount of inhaled gentamicin passing from the lungs into the systemic circulation was presumed to be insificant (7, 9, 10) . On endotracheal administration, however, urinary gentamicin excretion amounted to about 42% (8) , suggeting significant absorption from the lungs.
The aim of the present work was to study gentamicin kinetics after intravenous and intratracheal administration to rats.
MATERIALS AND METHODS
Gentamicin sulfate (Gentamycin, Pharmachim, Bulgaria) was administered in a dose of 8 mg and in a volume of 0.2 ml of the injection solution intratracheally to white, male rats weighing 200 to 230 g. Under ether anesthesia the trachea was exposed by incision in the neck area. Polyethylene tubing was inserted into the trachea between the third and fourth tracheal ring, and gentamicin solution was injected approximately at the bifurcation level. The rats were held in upright position for about 2 min after injection. The same dose of gentmicin was injected intravenously into the tail vein of another group of rats. Six to eight animals from both groups were investigated at each of the time intervals given below. With time intervals exceeding 60 min, the rats were placed into glass metabolic cages. On shorter time intervals, the urethras were tied up immediately after gentamicin administration. The rats were killed in ether anesthesia 2. drug per ml of culture medium for the above-mentioned strain. Overnight cultures of the strain were prepared in nutrient broth (Difco), and 1 ml of 102 dilution of the culture in distilled water (approximately 2 x i0' bacterial cells) was used for inoculation. Mueller-Hinton agar (pH 7.5; 1% NaCl) served as cultivation medium. Plastic petri dishes, 10 cm in diameter, were filled with 25 ml of the assay medium.
Six wells, 9 mm in diameter, were cut in each plate. They were filled with 0.15 ml of the solution analyzed. The plates were incubated for 18 h at 37°C. Each sample was analyzed in triplicate. The diameters of inhibition zones were determined with an accuracy of 0.5 mm. Known amounts of gentamicin were added to homogenates of normal rat tissues, and gentamicin recovery was asessed in supernatants of these tissue homogenates. The average recoveries from three experiments for the heart, lungs, liver, and kidneys were 89.8 ± 4.8, 68.0 ± 9.3, 78.5 ± 15.9, and 85.1 ± 8.2%, respectively. Corrections on incomplete recoveries were included in the data-processing program. Calibration curves of gentamicin were prepared for buffer, plasma, unne, and supernatants of the various organs analyzed. RESULTS Table 1 shows the time dependence of gentamicin concentrations in plama, heart, liver, kidneys, and lungs after a single intravenous or intratracheal dose of gentamicin. Table 2 shows percentage of administered gentamicin recovered in urine and lungs after intratracheal administration and in urine after intravenous administration.
The time dependence of the logarithm of gentamicin concentration in plasma after intravenous administration was approximated with the following function by means of the linear regression method: log C(t) = 0.311 -0.014 x t. This ANTIMICROB. AGENTS CHEMOTHER. of appearance of gentamicin in plasma after intratracheal administration, and F is the fraction of absorbed gentamicin in plasma after intratracheal administration (for t 2 ta). The value of F = 0.428 was determined (5) are the areas under the curve of the time dependence of gentamicin concentration in plasma after intratracheal and intravenous administration, respectively. DISCUSSION The experimental data presented show significant gentamicin absorption from rat lungs into the systemic circulation, which is in keeping with values reported in hums (8) . On comparing rat and human data, the species-specific differences in the structure of the lungs, as established by comparative morphometry ofmammalian lungs (13) , must be taken into account. Urinary recovery of gentamicin after intratracheal administration indicates an even greater mobilization of gentamicin from lungs. Provided that the absorption mechanisms of gentamicin from lungs after intratracheal and inhalation administration are comparable, the amount of gentamicin retained in lungs after inhalation of its aerosol (7, 9, 10) must have been grossly overestimated.
The one-compartment model was applied for the pharmacokinetic interpretation of obtained experimental data. The adequacy of this model is based on a good fit of plasma gentamicin after intravenous administration with the monoexponential function. The monoexponential decrease observed in the time interval of 0 to 120 min is in accordance with published data (7, 12) (6) .
Our data (see Table 1 ) have confirmed the _ndings of significant retention of gentamicin in the kidneys (1, 4) . After an initial decrease, an almost constant level of gentamicin in kidneys was seen after both modes of gentamicin administration.
A fraction of 72.2% of intravenously administered gentamicin was excreted in urine within 24 h. Retardation ofthe experimentally determined cumulative excretion of gentamicin compared with the calculated elimination based on plasma clearance was observed in accordance with previous reports (3, 6) . The possibility that gentamicin is retained in the urine contained in the renal tubuli remains to be established experimentally.
The relatively high single dose of 8 mg of gentamicin was chosen to enable direct comparison of our results with the key data (7), where the amount of gentamicin following a single inhalation was estimated to be 7.7 mg.
Intratracheal administration of a drug solution does not ideally reproduce the inhalation process of an aerosol prepared from this solution (2) . Nevertheless, a vast body of published papers indicates that this method has contributed to the study of inhalation toxicology and related disciplines.
